Nurix Therapeutics, Inc. (NRIX)
15.48
-0.89
(-5.44%)
USD |
NASDAQ |
Jun 03, 16:00
15.48
0.00 (0.00%)
After-Hours: 06:36
Nurix Therapeutics EPS Diluted (Quarterly) : -0.792 for Feb. 28, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ultragenyx Pharmaceutical, Inc. | -1.839 |
| Alpha Cognition, Inc. | -0.3208 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Anika Therapeutics, Inc. | -0.3737 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -87.17M |
| Revenue (Quarterly) | 6.252M |
| Total Expenses (Quarterly) | 93.43M |
| Enterprise Value | 1.119B |
| Gross Profit Margin (Quarterly) | 39.60% |
| Profit Margin (Quarterly) | -1.39K% |
| Earnings Yield | -20.41% |
| Normalized Earnings Yield | -20.41 |